Exploring Ambient Light Activatable Optogenetics for Vision Restoration in Retinal Degenerative Diseases

Time: 9:00 am
day: Day Two


  • Mutation-agnostic therapy with potential to be disease-agnostic platform
    therapy preclinical data
  • Clinical data on Retinitis Pigmentosa
  • Novel end points for low vision patients deployed in a multi-site randomized,
    sham-controlled optogenetic study